Skip to content

Cobas Fp Reagents for Digoxin & Cobas Fp Digoxin C

by Roche Diagnostic Systems, Inc. 510(k)

Active United States

510(k) K851032

Regulatory status

as of 29 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK851032 Date3 Apr 1985ClearedStatusActive

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Recalls

1 recall · FDA

    • Terminated Z-0736-2007 FDA Unclassified (pre-2012) initiated 16 Mar 2007

    The lower detection limit (LDL) may be a higher value than stated in the labeling. Note: To resolve this issue, the Digoxin LDL claim has been revised to 0.3 ng/mL for all reagent lots.

Specification

510(k)

510(k) Number
FDA Product Code
KXT
Device Class
Class II
Regulation
21 CFR Part 862.3320
Advisory Committee
Clinical Toxicology
FDA Decision
SESE Substantially Equivalent

Other devices from Roche Diagnostic Systems, Inc.

See all devices from Roche Diagnostic Systems, Inc. →